Article: FDA: erectile drugs may raise risk of sudden hearing loss.

[ILLUSTRATION OMITTED]

The U.S. Food and Drug Administration (FDA) has ordered labeling changes for erectile-dysfunction (ED) medications known as phosphodiesterase 5 inhibitors to reflect a potential risk of sudden hearing loss associated with using the drugs. The medications include sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra), as well as Revatio, used to treat pulmonary arterial hypertension. The FDA ordered the changes in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!